Related Experiment Video
Updated: Jun 28, 2025

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
Novel MIR143HG::PLAG1 gene fusion identified in a rectal myxoid leiomyosarcoma
Shuanzeng Wei1, Jianming Pei1, Paul Belser2
1Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Abstract:
Myxoid leiomyosarcoma (MLS) is a rare but well-documented tumor that often portends a poor prognosis compared to the conventional leiomyosarcoma. This rare sarcoma has been reported in the uterus, external female genitalia, soft tissue, and other locations. However, a definite rectal MLS has not been reported. Recently five cases of MLS were reported to harbor PLAG1 fusions (TRPS1::PLAG1, RAD51B::PLAG1, and TRIM13::PLAG1). In this report, we present a case of rectal MLS with a novel MIR143HG::PLAG1 fusion detected by RNA next-generation sequencing.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation

